Common MTHFR Variants vs. MTHFR Deficiency: What’s the Difference?

Few genes have received as much internet attention as MTHFR. Many people discover they have an MTHFR variant through genetic testing and worry that it explains fatigue, anxiety, infertility, miscarriages, chronic illness, or difficulty detoxing. At the same time, doctors also use the phrase MTHFR deficiency to describe a rare, serious inherited metabolic disorder.

Understanding the difference between these two conditions can prevent unnecessary fear while also helping families recognize when true medical evaluation is needed.

What Does MTHFR Do?

The MTHFR gene gives the body instructions for making an enzyme called methylenetetrahydrofolate reductase. This enzyme helps process folate, a B vitamin, and supports a biochemical pathway that helps recycle homocysteine, which causes inflammation, back into methionine. Methionine is then used to make compounds involved in growth, brain function, blood vessel health, pregnancy, and methylation.

When MTHFR activity is mildly reduced, homocysteine may rise slightly, especially if folate, vitamin B12, or other nutrients are low. When MTHFR activity is severely deficient, homocysteine can become very high, and methionine can become too low, creating a true metabolic disease.

Common MTHFR Variants: C677T and A1298C

The two common MTHFR variants are usually called C677T and A1298C. These are polymorphisms, meaning common differences in DNA that many people carry. They are not “mutations” in the frightening sense of the word.

The C677T variant can reduce MTHFR enzyme activity, especially when a person has two copies of the variant, often written as 677TT. The A1298C variant is generally associated with a milder reduction. These variants may more noticeably affect homocysteine when folate status is low.

Most people with common MTHFR variants do not have severe MTHFR deficiency. They also may or may not have symptoms. Common variants produce small to moderate changes in metabolic efficiency. Severe deficiency is a rare disorder in which the enzyme does not work well enough to maintain normal metabolism.

Comparing common MTHFR variants vs. Severe MTHFR Deficiency is like comparing apples to oranges.

Symptoms of Common MTHFR variants

For most people, common MTHFR variants do not cause disease, even though they may contribute to some symptoms. Many non-specific symptoms, such as fatigue, brain fog, anxiety, headaches, insomnia, or poor detoxification, can be associated. But these symptoms can also have many contributing factors. The risk of some medical conditions is also increased with MTHFR, including repeated miscarriages, infertility, some forms of cancer, hypothyroidism, and autoimmune disease.

Clinically, the most useful measures of function are the person’s homocysteine level, folate status, B12 status, medical history, and symptoms. Someone with a common MTHFR variant and normal homocysteine is very different from someone with an MTHFR variant and markedly elevated homocysteine.

Common variants may matter most when they occur alongside low folate intake, low B12, poor diet quality, high alcohol intake, certain medications, or other health stressors. The variant alone usually does not fully explain a complex health picture. These variants can be managed with diet, lifestyle, and supplement interventions, leaving the person experiencing those variants with excellent health.

Fertility and Pregnancy with Common MTHFR Variants

Folate is essential before and during pregnancy because it supports early fetal development and helps reduce the risk of neural tube defects. The common MTHFR variants, especially C677TT have been studied in relation to folate levels, neural tube defects, recurrent pregnancy loss, and other pregnancy outcomes. Many studies show associations, but results vary by population, folate and nutritional status, and study design.

For most people trying to conceive, the practical takeaway is not panic or excessive testing. It is to make sure folate status is well supported before pregnancy. Depending on your needs and tolerance, a prenatal vitamin containing methyl folate or folinic acid is best for anyone with an MTHFR variant. Everyone with recurrent pregnancy loss, infertility, clotting history, or high homocysteine should be evaluated individually.

Severe MTHFR Deficiency: a Rare Metabolic Disorder

Severe MTHFR deficiency is very different. It is a rare inherited condition, usually caused by two disease-causing variants (not the common variants) in the MTHFR gene. This can lead to homocystinuria (or homocysteine in the urine) due to MTHFR deficiency, with very high homocysteine and low methionine.

This condition often appears early in infancy, childhood, or adolescence, and rarely in adulthood. Earlier-onset cases are often more severe. Symptoms can include feeding problems, poor growth, low muscle tone, developmental delay, seizures, abnormal movements, trouble walking, intellectual disability, psychiatric symptoms, blood clots, stroke-like events, and progressive neurologic decline. Babies may appear normal at birth and then develop symptoms later.

In adults, severe MTHFR deficiency may be harder to recognize. It can sometimes look like a neurologic or psychiatric condition, with changes in walking, weakness, cognitive changes, mood symptoms, psychosis, seizures, or unexplained vascular events.

Quality of Life and Fertility in Severe MTHFR Deficiency

Untreated severe MTHFR deficiency has major effects on quality of life because the brain, blood vessels, and nervous system are vulnerable to disrupted homocysteine and methionine metabolism. Early recognition and treatment make a major difference.

Fertility and pregnancy with severe MTHFR deficiency require specialized care. A woman with true MTHFR deficiency may need close monitoring by a metabolic specialist, a maternal-fetal medicine specialist, and a genetics team. The goal is to maintain metabolic stability, reduce complications associated with high homocysteine levels, and support both mother and baby. This is very different from simply having a common C677T or A1298C variant.

How Severe MTHFR Deficiency is Discovered

Severe MTHFR deficiency may be detected through newborn screening, especially when screening reveals abnormal patterns of methionine and homocysteine. However, screening practices vary, and not every case is caught immediately. It may also be discovered after symptoms appear.

Doctors check plasma total homocysteine, amino acids including methionine, urine homocystine, vitamin B12, folate, methylmalonic acid, and other metabolic markers. Genetic testing can confirm disease-causing MTHFR variants. In some cases, enzyme testing may also be used. Severe deficiency usually produces a striking biochemical pattern. It is not diagnosed simply because someone has a common MTHFR polymorphism on a consumer DNA report.

How Severe MTHFR Deficiency is Managed

Management must be directed by specialists familiar with inherited metabolic disorders. Treatment often includes betaine, which helps the body remethylate homocysteine through an alternate pathway. Depending on the person, treatment may also include folinic acid or other folate forms, vitamin B12, methionine, and additional supportive therapies. Monitoring typically includes homocysteine, methionine, growth, neurologic development, clotting risk, and medication response. Research suggests that early betaine treatment can improve survival and developmental outcomes in severe MTHFR deficiency, which is why early diagnosis matters.

MTHFR Variants vs. MTHFR Deficiency

Common MTHFR variants and severe MTHFR deficiency live on the same gene, but they are not the same condition. Common variants such as C677T and A1298C are widespread and usually cause impairment in the MTHFR enzyme, but not loss of function. They may influence folate and homocysteine metabolism, especially when nutrient status is poor, but can also go undetected for a lifetime.

Severe MTHFR deficiency is rare, serious, and medically important. It causes debilitating impairment or complete loss of function of the MTHFR enzyme. It can cause high homocysteine, low methionine, neurologic symptoms, developmental problems, vascular complications, and major quality-of-life effects if not treated.

References

Frosst P, Blom HJ, Milos R, et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nature Genetics. 1995;10(1):111–113. doi:10.1038/ng0595-111.

Weisberg I, Tran P, Christensen B, Sibani S, Rozen R. A second genetic polymorphism in methylenetetrahydrofolate reductase associated with decreased enzyme activity. Molecular Genetics and Metabolism. 1998;64(3):169–172. doi:10.1006/mgme.1998.2714.

Hickey SE, Curry CJ, Toriello HV. ACMG Practice Guideline: lack of evidence for MTHFR polymorphism testing. Genetics in Medicine. 2013;15(2):153–156. doi:10.1038/gim.2012.165.

Huemer M, Diodato D, Schwahn B, et al. Guidelines for diagnosis and management of the cobalamin-related remethylation disorders and MTHFR deficiency. Journal of Inherited Metabolic Disease. 2017;40(1):21–48. doi:10.1007/s10545-016-9991-4.

Diekman EF, de Koning TJ, Verhoeven-Duif NM, Rovers MM, van Hasselt PM. Survival and psychomotor development with early betaine treatment in patients with severe methylenetetrahydrofolate reductase deficiency. JAMA Neurology. 2014;71(2):188–194. doi:10.1001/jamaneurol.2013.4915.

Du B, Shi X, Yin C, Feng X. Polymorphisms of methylenetetrahydrofolate reductase in recurrent pregnancy loss: an overview of systematic reviews and meta-analyses. Journal of Assisted Reproduction and Genetics. 2019;36(7):1315–1328. doi:10.1007/s10815-019-01473-2.